Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3065

Actual shortage: 232 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2809 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FAMCICLOVIR 125MG TABLET Resolved 2022-04-08 2022-05-13 158353
APO-IMATINIB 100MG TABLET Resolved 2022-04-08 2022-06-02 158358
APO-IMATINIB 400MG TABLET Resolved 2022-04-08 2022-06-03 158361
APO-METRONIDAZOLE 500MG CAPSULE Resolved 2022-04-08 2022-05-14 158364
APO-PREGABALIN 50MG CAPSULE Resolved 2022-04-08 2022-05-13 158367
APO-ROSUVASTATIN 5MG TABLET Resolved 2022-04-08 2022-04-22 158370
APO-TERBINAFINE 250MG TABLET Resolved 2022-04-08 2022-06-12 158373
APO-GEFITINIB 250MG TABLET Resolved 2022-04-14 2022-06-24 158819
APO-BECLOMETHASONE NASAL SPRAY 50MCG SUSPENSION Resolved 2022-04-29 2022-05-27 159695
APO-DIVALPROEX 250MG TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) Resolved 2022-04-29 2022-07-28 159700
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-12-17 159703
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Resolved 2022-04-29 2022-06-28 159713
APO-MIRTAZAPINE 30MG TABLET Resolved 2022-04-29 2022-06-03 159716
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-14 159719
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-22 159722
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-11-07 159725
APO-LEVOCARB-TAB 25MG/100MG 100MG 25MG TABLET Resolved 2022-05-06 2022-05-19 160138
APO-SOTALOL 80MG TABLET Resolved 2022-05-06 2022-07-15 160141
APO-TRYPTOPHAN 500MG CAPSULE Resolved 2022-05-06 2022-06-17 160144
APO-ACETAMINOPHEN 325MG TABLET Resolved 2022-05-13 2022-07-11 160601

Showing 2201 to 2220 of 3065

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977
APO-AMOXI SUGAR FREE 250MG POWDER FOR SUSPENSION Discontinued 2020-06-22 2020-06-22 118526
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-QUETIAPINE 25MG TABLET Discontinued 2021-06-25 2021-06-25 141546
APO-PINDOL TAB 5MG 5MG TABLET Discontinued 2022-02-09 2022-02-10 154568
APO-PINDOL TAB 10MG 10MG TABLET Discontinued 2022-02-09 2022-02-10 154571
APO-PINDOL TAB 15MG 15MG TABLET Discontinued 2022-02-09 2022-12-09 154574
MELPHALAN FOR INJECTION 10ML 50MG POWDER FOR SOLUTION KIT SOLUTION Discontinued 2022-03-23 2022-03-23 157136
APO-BICALUTAMIDE 50MG TABLET Discontinued 2022-03-25 2022-05-13 157376
APO-CLOBETASOL SPRAY 0.05% SPRAY Discontinued 2022-09-06 2022-09-06 168648
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 150MG 300MG TABLET Discontinued 2022-12-12 2022-12-12 177953
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Discontinued 2023-09-26 2023-11-02 205310
APO-CARVEDILOL 25MG TABLET Discontinued 2024-01-26 2024-01-27 217504
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40781
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40784
APO-ALENDRONATE 10MG TABLET To be discontinued 2018-09-07 2019-12-20 60163
APO-ATORVASTATIN 10MG TABLET To be discontinued 2018-09-07 2018-09-07 60276
APO-BRIMONIDINE 0.2% SOLUTION To be discontinued 2018-09-07 2018-09-07 60294
APO-BROMAZEPAM 1.5MG TABLET To be discontinued 2018-09-07 2018-09-07 60304

Showing 321 to 340 of 356